APOQUEL Back On Full Distribution
8 years ago 
1269 views
APOQUEL, the fast-acting oral therapy for the treatment of canine pruritus, is now available to all UK vet practices on unlimited distribution, following Zoetis’ commitment to upscale manufacture of the product.
As a result of unprecedented demand after APOQUEL’s launch last year, an allocation system was established to ensure that those dogs that had started on APOQUEL were able to remain on the medicine for as long as their vet deemed appropriate. During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
APOQUEL is the first Janus Kinase (JAK) inhibitor approved for veterinary use. It provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis comments: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that APOQUEL supply will better align with demand. We have reduced the length of time it takes to manufacture APOQUEL and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with APOQUEL fully back in stock and we’d like to thank all of our customers for their patience.”
For more information go to www.zoetis.co.uk/apoquel.
More from Zoetis
- Zoetis appoints new Inside Sales Account Manager
- Zoetis Equip® Artervac Supply Issue
- Zoetis UK Appoints Simon Dunne as Companion Animal Business Unit Director
- Zoetis UK: Update On The Supply Of Equip® Rotavirus
- Zoetis UK and StreetVet Announce Charity of the Year Partnership to Further Support the Human Animal Bond
